Provectus Biopharmaceuticals
(OTC) PVCT
Provectus Biopharmaceuticals Financials at a Glance
Market Cap
$20.88M
Revenue (TTM)
$336.11K
Net Income (TTM)
$5.47M
EPS (TTM)
$-0.01
P/E Ratio
-3.85
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$0.05
Volume
429,394
Open
$0.05
Price
$0.05
Volume
429,394
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.04 - $0.10
Dividend
$0.00
Beta (Volatility)
0.29 (Low)
Price
$0.05
Volume
429,394
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.04 - $0.10
PVCT News
5 of Last Week's Biggest Losers
PVCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Provectus Biopharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
6
CEO
Edward V. Pershing, CPA
Website
www.provectusbio.comHeadquarters
Knoxville, TN 37932, US
PVCT Financials
Key Financial Metrics (TTM)
Gross Margin
-14%
Operating Margin
-15%
Net Income Margin
-16%
Return on Equity
0%
Return on Capital
82%
Return on Assets
-8%
Earnings Yield
-25.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.88M
Shares Outstanding
420.28M
Volume
429.39K
Short Interest
0.00%
Avg. Volume
361.76K
Financials (TTM)
Gross Profit
$334.25K
Operating Income
$4.84M
EBITDA
$4.84M
Operating Cash Flow
$3.33M
Capital Expenditure
$0.00
Free Cash Flow
$3.33M
Cash & ST Invst.
$251.29K
Total Debt
$4.72M
Provectus Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$465.00
-103.4%
Gross Margin
0.00%
N/A
Market Cap
$20.88M
N/A
Market Cap/Employee
$3.48M
N/A
Employees
6
N/A
Net Income
$1.17M
+51.4%
EBITDA
$1.02M
+56.2%
Quarterly Fundamentals
Net Cash
$4.47M
-55.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$102.84K
N/A
Short Term Debt
$4.62M
+44.9%
Return on Assets
-7.84%
N/A
Return on Invested Capital
82.11%
N/A
Free Cash Flow
$869.55K
+4.7%
Operating Cash Flow
$869.55K
+4.7%